Table 1 Baseline characteristicsa.
Mean ± SD | |
---|---|
Gender, n (F/M) | 3/13 |
Age, years | 66 ± 6 |
Body weight, kg | 90.8 ± 15.4 |
Height, cm | 174.7 ± 8.1 |
BMI, kg/m2 | 29.6 ± 3.3 |
Fasting glucose, mmol/L | 8.4 ± 1.5 |
HbA1c, % | 6.5 ± 0.6 |
ASAT, U/L | 23.8 ± 3.9 |
ALAT, U/L | 30.3 ± 7.7 |
GGT, U/L | 32.6 ± 14.6 |
Potassium (mmol/L) | 4.5 ± 0.1 |
Creatinine (µmol/L) | 84.8 ± 4.8 |
Bilirubin | 12.1 ± 2.8 |
Hemoglobin (mmol/L) | 8.8 ± 0.2 |
Oral glucose lowering medication, n | 16 |
Metformin only | 8 |
Sulphonylurea derivates only | 2 |
Metformin + sulphonylurea derivates | 6 |